{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06229977",
            "orgStudyIdInfo": {
                "id": "HSC-MS-21-0989"
            },
            "organization": {
                "fullName": "The University of Texas Health Science Center, Houston",
                "class": "OTHER"
            },
            "briefTitle": "A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression",
            "officialTitle": "A Randomized Controlled Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression",
            "therapeuticArea": [
                "Mental Health"
            ],
            "study": "a-trial-of-the-fatty-acid-amide-hydrolase-inhibitor-palmitoylethanolamide-in-bipolar-depression"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-05-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-19",
            "studyFirstSubmitQcDate": "2024-01-19",
            "studyFirstPostDateStruct": {
                "date": "2024-01-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Rodrigo Machado-Vieira, MD, PhD, MSc",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "The University of Texas Health Science Center, Houston"
            },
            "leadSponsor": {
                "name": "The University of Texas Health Science Center, Houston",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Baszucki Brain Research Fund",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to o evaluate the antidepressant efficacy of the PEA in Bipolar Depression and the association between antidepressant response with endogenous cannabinoids and cytokine levels"
        },
        "conditionsModule": {
            "conditions": [
                "Bipolar Depression"
            ],
            "keywords": [
                "cytokine levels"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "PEA plus Treatment as Usual (TAU)",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Palmitoylethanolamide (PEA)",
                        "Drug: Treatment as Usual (TAU)"
                    ]
                },
                {
                    "label": "Placebo plus Treatment as Usual (TAU)",
                    "type": "PLACEBO_COMPARATOR",
                    "interventionNames": [
                        "Drug: Placebo",
                        "Drug: Treatment as Usual (TAU)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Palmitoylethanolamide (PEA)",
                    "description": "Participants will receive PEA at a dose of 600mg twice daily for 6 weeks.",
                    "armGroupLabels": [
                        "PEA plus Treatment as Usual (TAU)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Participants will receive placebo (a tablet that contains no active ingredient) to be taken twice daily for 6 weeks",
                    "armGroupLabels": [
                        "Placebo plus Treatment as Usual (TAU)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Treatment as Usual (TAU)",
                    "description": "subjects will receive a mood stabilizer per usual care",
                    "armGroupLabels": [
                        "PEA plus Treatment as Usual (TAU)",
                        "Placebo plus Treatment as Usual (TAU)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in depression as assessed by the Hamilton Depression rating Scale (HAM-D)",
                    "description": "This is a 13 item questionnaire and each is scored from 0-2 for a maximum score of 26 , a higher score indicating worse outcome",
                    "timeFrame": "Baseline, 6 weeks follow up"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of participants that show a remission of depressive symptoms as assessed by the HAM-D scale.",
                    "description": "Remission of depressive symptoms are defined by a score of \u22647 on the HAM-D. This is a 13 item questionnaire and each is scored from 0-2 for a maximum score of 26 , a higher score indicating worse outcome",
                    "timeFrame": "from baseline to end of study (6 week follow up)"
                },
                {
                    "measure": "Percentage of participants that show a response as assessed by the HAM-D scale",
                    "description": "Response rate is defined by \u2265 50 % reduction in depression score(HAM-D). This is a 13 item questionnaire and each is scored from 0-2 for a maximum score of 26 , a higher score indicating worse outcome",
                    "timeFrame": "from baseline to end of study (6 week follow up)"
                },
                {
                    "measure": "Number of participants that show early improvement as defined by >20% improvement in HAM-D depression score",
                    "description": "This is a 13 item questionnaire and each is scored from 0-2 for a maximum score of 26 , a higher score indicating worse outcome",
                    "timeFrame": "From baseline to week 2 visit"
                },
                {
                    "measure": "Change in depression as assessed by the Montgomery \u00c4sberg Depression Rating Scale (MADRS)",
                    "description": "This is a 10 item questionnaire and each is scored from 0 -6 for a maximum score of 60, higher score indicating worse outcome",
                    "timeFrame": "Baseline, 6 weeks follow up"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of Bipolar Disorder according to the Diagnostic and Statistical Manual of Mental Disorders (Structured Clinical Interview), Fifth Edition, (DSM5), with a score of \u226516 on the 17-item HAM-D\n* currently in use of at least one FDA approved mood stabilizer with or without antidepressant\n* medically and neurologically healthy on the basis of medical history, physical examination\n\nExclusion Criteria:\n\n* Cannabis misuse according to clinical judgement\n* unstable medical condition or uncontrolled medical problem with known central nervous system (CNS) effects\n* active DSM-5 substance use disorder in past three months (other than alcohol or nicotine use disorder)\n* acute high suicidal risk\n* in a manic episode\n* current psychotic features or cognitive impairment that would preclude understanding of the consenting process or tests/examination\n* pregnant or nursing women\n* unstable medical conditions\n* clinically significant abnormal laboratory tests based on complete blood count, liver and kidney function when available",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rodrigo Machado-Vieira, M.D, Ph.D., M.Sc",
                    "role": "CONTACT",
                    "phone": "(713) 486-2581",
                    "email": "Rodrigo.MachadoVieira@uth.tmc.edu"
                },
                {
                    "name": "Abdul Haseeb",
                    "role": "CONTACT",
                    "phone": "(713) 486-2700",
                    "email": "Abdul.Haseeb@uth.tmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Rodrigo Machado-Vieira, M.D, Ph.D., M.Sc",
                    "affiliation": "The University of Texas Health Science Center, Houston",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The University of Texas Health Science Center at Houston",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rodrigo Machado-Vieira, M.D, Ph.D., M.Sc",
                            "role": "CONTACT",
                            "phone": "(713) 486-2581",
                            "email": "Rodrigo.MachadoVieira@uth.tmc.edu"
                        },
                        {
                            "name": "Abdul Haseeb",
                            "role": "CONTACT",
                            "phone": "(713) 486-2700",
                            "email": "Abdul.Haseeb@uth.tmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003863",
                    "term": "Depression"
                },
                {
                    "id": "D000003866",
                    "term": "Depressive Disorder"
                },
                {
                    "id": "D000001714",
                    "term": "Bipolar Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001526",
                    "term": "Behavioral Symptoms"
                },
                {
                    "id": "D000019964",
                    "term": "Mood Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                },
                {
                    "id": "D000068105",
                    "term": "Bipolar and Related Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7058",
                    "name": "Depression",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7061",
                    "name": "Depressive Disorder",
                    "asFound": "Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4996",
                    "name": "Bipolar Disorder",
                    "asFound": "Bipolar Depression",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4818",
                    "name": "Behavioral Symptoms",
                    "relevance": "LOW"
                },
                {
                    "id": "M21835",
                    "name": "Mood Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M226",
                    "name": "Bipolar and Related Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000005958",
                    "term": "Palmidrol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000894",
                    "term": "Anti-Inflammatory Agents, Non-Steroidal"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                },
                {
                    "id": "D000063386",
                    "term": "Cannabinoid Receptor Agonists"
                },
                {
                    "id": "D000063385",
                    "term": "Cannabinoid Receptor Modulators"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M340341",
                    "name": "Palmidrol",
                    "asFound": "Psychosocial support",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M4218",
                    "name": "Anti-Inflammatory Agents, Non-Steroidal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}